Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia.
Yang J, Zhang Y, Li YC, Wang QX, Zhang MY, Xu YJ, Wang JJ, Liang XT, Jing XL, Zhou SS, Li QQ, Wang ZX, Zhou Y, Qiao N, Wei TH, Ding N, Xue X, Yu YC, Wang XL, Sun SL, Dai WC, Li NG, Shi ZH.
Yang J, et al. Among authors: li qq.
Drug Dev Res. 2024 Dec;85(8):e70022. doi: 10.1002/ddr.70022.
Drug Dev Res. 2024.
PMID: 39569546